3.62 ± 1.10, P = 0.048) were marginally significant.
← all excerpts
Effect of zinc supplementation on atherogenic risk indices in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial.
1
—
—
3.62 ± 1.10, P = 0.048) were marginally significant.